Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in postmenopausal women treated with percutaneous estradiol

被引:7
作者
Suvanto-Luukkonen, E [1 ]
Sundstrom, H
Penttinen, J
Kauppila, A
机构
[1] Oulu Univ, Cent Hosp, Dept Obstet & Gynecol, SF-90220 Oulu, Finland
[2] Kainuu Cent Hosp, Dept Obstet & Gynecol, Kajaani, Finland
关键词
lipids; hormone replacement therapy; levonorgestrel; natural progesterone;
D O I
10.1007/s004040050222
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: The ideal progestin for combined hormone replacement therapy should be free of adverse effects on lipid metabolism. We therefore examined lipid profiles during continuous hormone replacement therapy (HRT) with an estradiol-gel combined with either a levonorgestrel-releasing intrauterine device (LNG-IUD) or oral/vaginal natural progesterone. Methods: Sixty menopausal women recruited in this open, non-randomised parallel three-group study received percutaneous gel containing 1.5 mg of estradiol daily. Progestin was administered to the women with an LNG-IUD (n = 20), as oral natural progesterone (n = 21) 100 mg daily on the 1 - 25 calendar days of the month or as vaginal progesterone (n = 19) 100 - 200 mg daily on the 1 - 25 calendar days of the month. Serum concentrations for total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides and sex hormone binding globulin (SHBG) were measured at 0, 6 and 12 months. The median (and 95% confidence interval) of the serum SHBG, total, LDL-, HDL-cholesterol and triglycerides concentrations at baseline and after 6 and 12 months of the study and the ratio of 6 and 12 months values to baseline values were calculated. Results: Total cholesterol was significantly decreased (8%) in the vaginal progesterone group at the end of the trial. HDL-cholesterol did not change in either of the progesterone groups, while a slight but transient decrease (median 15%) was seen at 6 months in the LNG-IUD group. There were no significant changes in triglycerides or LDL-cholesterol concentrations in any group. SHBG did not change significantly in the LNG-IUD and vaginal progesterone groups, while a slight but transient increase was seen in oral P group at 6 months. Conclusions: As the only significant harmful effect observed was a transient decrease in HDL-cholesterol in the LNG-IUD group at 6 months, each of these HRT-administration methods can be regarded as being safe in their effects on lipid metabolism.
引用
收藏
页码:201 / 208
页数:8
相关论文
共 12 条
[1]  
ANDERSSON K, 1992, OBSTET GYNECOL, V79, P963
[2]   TRANSDERMAL ESTRADIOL AND CARDIOVASCULAR RISK-FACTORS [J].
CHEANG, A ;
SITRUKWARE, R ;
SAMSIOE, G .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1994, 101 (07) :571-581
[3]   EFFECTS ON LIPIDS AND LIPOPROTEINS IN WOMEN TREATED WITH ESTRADIOL AND PROGESTERONE [J].
DARJ, E ;
CRONA, N ;
NILSSON, S .
MATURITAS, 1992, 15 (03) :209-215
[4]   THE BENEFITS AND RISKS OF HORMONE REPLACEMENT THERAPY - AN EPIDEMIOLOGIC OVERVIEW [J].
HARLAP, S .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (06) :1986-1992
[5]   LONG-TERM EFFECTS OF PERCUTANEOUS ESTROGENS AND ORAL PROGESTERONE ON SERUM-LIPOPROTEINS IN POSTMENOPAUSAL WOMEN [J].
JENSEN, J ;
RIIS, BJ ;
STROM, V ;
NILAS, L ;
CHRISTIANSEN, C .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 156 (01) :66-71
[6]   CHANGES IN PLASMA-LIPOPROTEIN AND APOLIPOPROTEIN COMPOSITION IN RELATION TO ORAL VERSUS PERCUTANEOUS ADMINISTRATION OF ESTROGEN ALONE OR IN CYCLIC ASSOCIATION WITH UTROGESTAN IN MENOPAUSAL WOMEN [J].
MOORJANI, S ;
DUPONT, A ;
LABRIE, F ;
DELIGNIERES, B ;
CUSAN, L ;
DUPONT, P ;
MAILLOUX, J ;
LUPIEN, PJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (02) :373-379
[7]  
MOSNIERPUDAR H, 1991, ARCH MAL COEUR VAISS, V84, P1111
[8]   ASSOCIATION OF HORMONE-REPLACEMENT THERAPY WITH VARIOUS CARDIOVASCULAR RISK-FACTORS IN POSTMENOPAUSAL WOMEN [J].
NABULSI, AA ;
FOLSOM, AR ;
WHITE, A ;
PATSCH, W ;
HEISS, G ;
WU, KK ;
SZKLO, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (15) :1069-1075
[9]   EFFECTS OF ESTRADIOL ADMINISTRATION VIA DIFFERENT ROUTES ON THE LIPID PROFILE IN WOMEN WITH BILATERAL OOPHORECTOMY [J].
PALACIOS, S ;
MENENDEZ, C ;
JURADO, AR ;
VARGAS, JC .
MATURITAS, 1994, 18 (03) :239-244
[10]   SERUM-LIPIDS AND LIPOPROTEINS IN POSTMENOPAUSAL WOMEN RECEIVING TRANSDERMAL ESTROGEN IN COMBINATION WITH A LEVONORGESTREL-RELEASING INTRAUTERINE-DEVICE [J].
RAUDASKOSKI, TH ;
TOMAS, EI ;
PAAKKARI, IA ;
KAUPPILA, AJ ;
LAATIKAINEN, TJ .
MATURITAS, 1995, 22 (01) :47-53